These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18942708)

  • 21. Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters.
    Xia QY; Liu S; Li FQ; Huang WB; Shi LN; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(8):1610-6. PubMed ID: 23923079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
    Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
    Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J
    Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
    Bricard G; Bouzourene H; Martinet O; Rimoldi D; Halkic N; Gillet M; Chaubert P; Macdonald HR; Romero P; Cerottini JC; Speiser DE
    J Immunol; 2005 Feb; 174(3):1709-16. PubMed ID: 15661935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of MAGE, GAGE, and BAGE genes in human hepatocellular carcinoma].
    Shao JB; Chen Z
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):142-4. PubMed ID: 12681058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA; Neel HB; Strome SE; Roche P
    Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
    Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
    BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors.
    Ghadban T; Perez DR; Vashist YK; Bockhorn M; Koenig AM; El Gammal AT; Izbicki JR; Metzger U; Hauswirth F; Frosina D; Jungbluth AA
    Eur J Surg Oncol; 2014 Oct; 40(10):1307-12. PubMed ID: 24713551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
    Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
    Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma.
    Zerbini A; Pilli M; Soliani P; Ziegler S; Pelosi G; Orlandini A; Cavallo C; Uggeri J; Scandroglio R; Crafa P; Spagnoli GC; Ferrari C; Missale G
    J Hepatol; 2004 Jan; 40(1):102-9. PubMed ID: 14672620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
    Utsunomiya T; Inoue H; Tanaka F; Yamaguchi H; Ohta M; Okamoto M; Mimori K; Mori M
    Ann Surg Oncol; 2004 Oct; 11(10):934-40. PubMed ID: 15466353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The expression of 11 cancer/testis (CT) antigen genes in esophageal carcinoma].
    Liang Z; Sun ZY; Yuan YH; Han Y; Wang Y; Gu J; Zhang LJ
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):534-7. PubMed ID: 16438850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expressions of cancer-testis antigens in human hepatocellular carcinomas.
    Chen CH; Chen GJ; Lee HS; Huang GT; Yang PM; Tsai LJ; Chen DS; Sheu JC
    Cancer Lett; 2001 Mar; 164(2):189-95. PubMed ID: 11179834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
    Bolli M; Schultz-Thater E; Zajac P; Guller U; Feder C; Sanguedolce F; Carafa V; Terracciano L; Hudolin T; Spagnoli GC; Tornillo L
    Int J Cancer; 2005 Jul; 115(6):960-6. PubMed ID: 15751033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.